these studies demonstrate ( a ) significant protein loss as one etiologic factor for protein metabolic disturbances in the human and experimental rat blind-loop syndrome , ( b ) the occurrence of intestinal protein loss as a manifestation of functionally significant mucosal injury in the contaminated nonstagnant small bowel as well as the stagnant part of the small intestine affected by bacterial overgrowth , and ( c ) the difficulty of reversing functionally significant mucosal injury in the blind-loop syndrome once it has been manifest .
C0021853
intestinal
C0005750
blind-loop syndrome